Table 1 Demographic characteristics
From: Artemether-lumefantrine efficacy among adults on antiretroviral therapy in Malawi
Overall | Ndirande | Zomba | |
|---|---|---|---|
Number of participants | 186 | 97 | 89 |
Study arm | |||
CQ, N(%) | 16 (8.6) | 11 (11.3) | 5 (5.6) |
TS, N(%) | 25 (13.4) | 15 (15.5) | 10 (11.2) |
No prophylaxis, N(%) | 145 (78.0) | 71 (73.2) | 74 (83.2) |
Follow up time, days, median (IQR) | 924 (756, 1,596) | 1,596 (1,315, 1,833) | 756 (686, 840) |
Age (years), mean (SD) | 42.0 (9.9) | 40.3 (9.6) | 43.7 (9.9) |
Sex | |||
Female, N(%) | 147 (79.0) | 78 (80.4) | 69 (77.5) |
BMI (kg/m2) | |||
Underweight (< 18.5) | 15 (8.1) | 6 (6.2) | 9 (10.1) |
Healthy weight (18.5–24.9) | 142 (76.3) | 69 (71.1) | 73 (82.0) |
Overweight (25–29.9) | 22 (11.8) | 16 (16.5) | 6 (6.7) |
Obese (30 or greater) | 7 (3.8) | 6 (6.2) | 1 (1.1) |
ART regimen (7 missing) | |||
With EFV, N(%) | 142 (79.3) | 70 (72.2) | 72 (87.8) |
Non EFV, N(%) | 37 (20.7) | 27 (27.8) | 10 (12.2) |
Bed net use | |||
Never, N(%) | 51 (27.4) | 26 (26.8) | 25(28.1) |
Last night, N(%) | 133 (71.5) | 69 (71.1) | 64 (71.9) |
Number of Clinical Malaria Episodes, mean (range) | 2.4 (1, 14) | 1.4 (1, 5) | 3.5 (1, 14) |
Parasite density on day 0 of malaria episode, geometric mean (95% CI) | 3394 (2828, 4073) | 3278 (2322, 4629) | 3450 (2783, 4278) |